Project Grant R43DE034602
Award Date
4/8/25
Completion Date
4/7/26
Dollars Obligated
$307K
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
This federal Project Grant award by the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $476,287 in funding to the Regents of the University of Michigan to research the role of the MERTK receptor tyrosine kinase in alveolar bone regeneration. The key focus of this project is to examine how MERTK signaling regulates alveolar bone stem cells and immune cell recruitment during the alveolar bone healing...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $304,019 to Panorama Research Incorporated to develop a novel therapeutic antibody to prevent alveolar bone loss in severe periodontitis. The research aims to identify and evaluate a panel of human anti-human OC-STAMP monoclonal antibodies, with the goal of selecting a lead candidate to potentially slow or halt the loss...
The National Institute of Dental and Craniofacial Research (NIDCR), part of the Department of Health and Human Services, awarded a $847,000 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to the University of Utah. The 2-year grant, awarded on August 1, 2023, will fund research to develop and evaluate the efficacy of a novel antimicrobial bone scaffold made from zinc-doped fluorapatite for use in craniofacial surgical applications. The research aims to...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) totals $588,952 and will run from April 2025 to March 2030. The funding will support the development and optimization of a bio-inspired tubular matrix scaffold to guide the formation of periodontal ligament (PDL) principal fibers and rebuild the microenvironment for the regeneration of Sharpey's fibers, which are critical for...
This $429,000 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) will fund research on differential responses of jawbone versus long bone cells to bone growth factor signaling and mechanical loading. The research aims to provide novel molecular insights into unique mechanisms governing jawbone health, with the goal of improving physical and pharmacological interventions for...
The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), awarded a $243,750 Project Grant to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The award, effective August 12, 2024, with a completion date of July 31, 2026, will support research to determine whether the FDA-approved iron oxide nanoparticle formulation ferumoxytol can...
This federal Project Grant award of $499,105 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), aims to develop a novel miRNA-based therapeutic to enhance bone regeneration and suppress bone resorption for advanced oral squamous cell carcinoma (OSCC) patients. The key products and services to be delivered include: Determining the functions of miR-200c in promoting mandibular bone regeneration under...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), provides $663,168 to develop multi-functional 3D printed dental implants to prevent peri-implantitis, a common and challenging implant-related oral infection. The project aims to create silver-doped amorphous magnesium phosphate bioceramic particles and incorporate them into a high-performance polyetheretherketone...
This $923,623 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), aims to advance the development of a first-in-class cyclic peptide (VTC-880) for the treatment and prevention of gingivitis and periodontitis. The key objectives of this 2-year project are to: manufacture the peptide and establish potency/analytical assays; determine the optimal formulation and in vitro pharmacokinetics...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), part of the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), provides $109,548.00 to the University of Alabama at Birmingham to support research on the role of the RUNX2 transcription factor in postnatal dentin synthesis and alveolar bone formation. The research aims to elucidate the regulatory mechanisms by which RUNX2 governs dentin and alveolar bone development, with...